TY - JOUR
T1 - Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
AU - on behalf of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long-Term Registry Investigators
AU - Kapłon-Cieślicka, Agnieszka
AU - Benson, Lina
AU - Chioncel, Ovidiu
AU - Crespo-Leiro, Maria G.
AU - Coats, Andrew J.S.
AU - Anker, Stefan D.
AU - Ruschitzka, Frank
AU - Hage, Camilla
AU - Drożdż, Jarosław
AU - Seferovic, Petar
AU - Rosano, Giuseppe M.C.
AU - Piepoli, Massimo
AU - Mebazaa, Alexandre
AU - McDonagh, Theresa
AU - Lainscak, Mitja
AU - Savarese, Gianluigi
AU - Ferrari, Roberto
AU - Mullens, Wilfried
AU - Bayes-Genis, Antoni
AU - Maggioni, Aldo P.
AU - Lund, Lars H.
AU - Gale, Christopher Peter
AU - Beleslin, Branko
AU - Budaj, Andrzej
AU - Chioncel, Ovidiu
AU - Dagres, Nikolaos
AU - Danchin, Nicolas
AU - Erlinge, David
AU - Emberson, Jonathan
AU - Glikson, Michael
AU - Gray, Alastair
AU - Kayikcioglu, Meral
AU - Maggioni, Aldo
AU - Nagy, Klaudia Vivien
AU - Nedoshivin, Aleksandr
AU - Petronio, Anna Sonia
AU - Roos-Hesselink, Jolien
AU - Wallentin, Lars
AU - Zeymer, Uwe
AU - Crespo-Leiro, M.
AU - Anker, S.
AU - Mebazaa, A.
AU - Coats, A.
AU - Filippatos, G.
AU - Ferrari, R.
AU - Maggioni, A. P.
AU - Piepoli, M. F.
AU - Goda, A.
AU - Diez, M.
AU - Abdulkarim, A. F.
N1 - Publisher Copyright:
© 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2023/9
Y1 - 2023/9
N2 - Aims: To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. Methods and results: Of 8298 patients in the European Society of Cardiology Heart Failure Long-Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non-use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers. In-hospital death occurred in 3.3%. The prevalence of hyponatraemia and in-hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in-hospital mortality 6.9%), 11% Yes/No (in-hospital mortality 4.9%), 8% No/Yes (in-hospital mortality 4.7%), and 72% No/No (in-hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In-hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12-month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35–1.89), Yes/No 1.35 (1.14–1.59), and No/Yes 1.18 (0.96–1.45). For death or heart failure hospitalization they were 1.38 (1.21–1.58), 1.17 (1.02–1.33), and 1.09 (0.93–1.27), respectively. Conclusion: Among patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in-hospital and post-discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk.
AB - Aims: To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. Methods and results: Of 8298 patients in the European Society of Cardiology Heart Failure Long-Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non-use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers. In-hospital death occurred in 3.3%. The prevalence of hyponatraemia and in-hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in-hospital mortality 6.9%), 11% Yes/No (in-hospital mortality 4.9%), 8% No/Yes (in-hospital mortality 4.7%), and 72% No/No (in-hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In-hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12-month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35–1.89), Yes/No 1.35 (1.14–1.59), and No/Yes 1.18 (0.96–1.45). For death or heart failure hospitalization they were 1.38 (1.21–1.58), 1.17 (1.02–1.33), and 1.09 (0.93–1.27), respectively. Conclusion: Among patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in-hospital and post-discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk.
KW - Acute heart failure
KW - Congestion
KW - Hyponatraemia
KW - Prognosis
KW - Sodium
KW - Worsening heart failure
UR - http://www.scopus.com/inward/record.url?scp=85160057555&partnerID=8YFLogxK
U2 - 10.1002/ejhf.2873
DO - 10.1002/ejhf.2873
M3 - Article
AN - SCOPUS:85160057555
SN - 1388-9842
VL - 25
SP - 1571
EP - 1583
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 9
ER -